🇮🇳IN
Sign In
DI

DIVISLAB

NSE

Divi's Laboratories Limited

₹10,064.00

+118.50(+1.19%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into DIVISLAB. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

DIVISLAB exposure summary

Divi's Laboratories Limited reports a single business segment, Manufacture of Active Pharmaceutical Ingredients, Intermediates and Nutraceutical Ingredients.. Divi's Laboratories Limited is a constituent of 11 indices, with its largest weights in NIFTY Pharma (11.98%), NIFTY Healthcare Index (10.57%), NIFTY Next 50 (4.81%). 27 exchange-traded funds hold the stock.

Index memberships11
ETFs holding27

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer